Literature DB >> 22524665

Plasmablastic lymphoma in an elderly immunocompetent patient.

Makoto Takeuchi1, Fumi Ogawa, Tetsuo Onishi, Yasuhiro Moriyama.   

Abstract

Plasmablastic lymphoma (PBL) is a distinct type of diffuse B cell lymphoma that typically occurs in the oral cavity of patients with HIV infection or immunodeficiency status. PBL is characterized by its plasmablastic morphology and an immunophenotype indicative of a plasma cell differentiation. We present a case of a 75-year-old HIV-negative and Epstein-Barr virus (EBV)-negative patient presenting with an isolated oral cavity mass. The tumor consisted of a monotonous proliferation of undifferentiated large cells with relatively abundant cytoplasm, eccentrically located round nuclei with prominent nucleoli and numerous mitoses. Immunohistochemically, these cells were negative for CD45 and B cell antigens, while they showed diffuse positivity of CD138 and focal staining for epithelial membrane antigen (EMA), indicating plasma cell differentiation. Based on these histopathological and immunohistochemical characteristics, we diagnosed it as PBL. The patient received chemotherapy and is alive with locally persistent disease 3 years after diagnosis. To date, only several cases of oral PBL have been reported in HIV-negative, EBV-negative and immunocompetent patients. PBL should be included in the differential diagnosis of oral mass lesions and careful evaluation of the morphology and awareness of the existence of this uncommon type of lymphoma can lead to a correct diagnosis.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524665     DOI: 10.1111/j.1440-1827.2012.02798.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

Review 1.  Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.

Authors:  Jia-Zhu Wu; Ke Min; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.

Authors:  Min Liu; Bailong Liu; Bin Liu; Qiang Wang; Lijuan Ding; Chengcheng Xia; Lihua Dong
Journal:  Oncol Rep       Date:  2015-02-17       Impact factor: 3.906

3.  Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.

Authors:  Li Lin; Xudong Zhang; Meng Dong; Ling Li; Xinhua Wang; Lei Zhang; Xiaorui Fu; Zhenchang Sun; Jingjing Wu; Zhaoming Li; Yu Chang; Yingjun Wang; Zhiyuan Zhou; Mingzhi Zhang; Qingjiang Chen
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].

Authors:  X Han; L X Hu; M Q Ouyang; M H Duan; D B Zhou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

5.  Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.

Authors:  Lili Cheng; Qi Song; Mengke Liu; Yan Wang; Hongmei Yi; Ying Qian; Pengpeng Xu; Shu Cheng; Chaofu Wang; Li Wang; Weili Zhao
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.